...
首页> 外文期刊>Antioxidants and redox signalling >Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy
【24h】

Epigenetic Histone Modifications Involved in Profibrotic Gene Regulation by 12/15-Lipoxygenase and Its Oxidized Lipid Products in Diabetic Nephropathy

机译:在糖尿病肾病中,12/15-脂氧合酶及其氧化脂产物中涉及引发基因调控的表观遗传组蛋白修饰

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims: Epigenetic mechanisms, including histone post-translational modifications and DNA methylation, are implicated in the pathogenesis of diabetic nephropathy (DN), but the mediators are not well known. Moreover, although dyslipidemia contributes to DN, epigenetic changes triggered by lipids are unclear. In diabetes, increased expression of 12/15-lipoxygenase (12/15-LO) enhances oxidized lipids such as 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE], which promote oxidant stress, glomerular and mesangial cell (MC) dysfunction, and fibrosis, and mediate the actions of profibrotic growth factors. We hypothesized that 12/15-LO and its oxidized lipid products can regulate epigenetic mechanisms mediating profibrotic gene expression related to DN. Results: 12(S)-HETE increased profibrotic gene expression and enrichment of permissive histone lysine modifications at their promoters in MCs. 12(S)-HETE also increased protein levels of SET7, a histone H3 lysine 4 methyltransferase, and promoted its nuclear translocation and enrichment at profibrotic gene promoters. Furthermore, SET7 (Setd7) gene silencing inhibited 12(S)-HETE-induced profibrotic gene expression. 12/15-LO (Alox15) gene silencing or genetic knockout inhibited transforming growth factor-beta 1 (TGF-beta 1)-induced expression of Setd7 and profibrotic genes and histone modifications in MCs. Furthermore, 12/15-LO knockout in mice ameliorated key features of DN and abrogated increases in renal SET7 and profibrotic genes. Additionally, 12/15-LO siRNAs in vivo blocked increases in renal SET7 and profibrotic genes in diabetic mice. Innovation and Conclusion: These novel results demonstrate for the first time that 12/15-LO-derived oxidized lipids regulate histone modifications associated with profibrotic gene expression in MCs, and 12/15-LO can mediate similar actions of TGF-beta 1 and diabetes. Targeting 12/15-LO might be a useful strategy to inhibit key epigenetic mechanisms involved in DN. Antioxid. Redox Signal. 24, 361-375.
机译:目的:表观遗传机制,包括组蛋白翻译后修饰和DNA甲基化,涉及糖尿病肾病(DN)的发病机制,但介质是众所周知的。此外,虽然血脂血症有助于DN,但是脂质引发的表观遗传变化尚不清楚。在糖尿病中,12 / 15-脂氧合酶(12/15-LO)的表达增加增强了氧化脂质,例如12(S) - 羟基辛醚四烯酸[12(S) - 培养],其促进氧化胁迫,肾小球和乳房细胞(MC )功能障碍和纤维化,并介绍突触型生长因子的作用。我们假设12/15-LO及其氧化的脂质产品可以调节介导与DN相关的研究媒体学基因表达的表观遗传机制。结果:12(S) - 在MCS中的促进剂中增加了促进基因表达和富集允许组蛋白赖氨酸修饰的富集。 12(s)培养还增加了Set7的蛋白质水平,组蛋白H3赖氨酸4甲基转移酶,并促进其在血频性基因启动子上促进其核易位和富集。此外,Set7(SetD7)基因沉默抑制了12(S)诱导诱导的突触式基因表达。 12/15-LO(Alox15)基因沉默或遗传敲除抑制转化生长因子-β1(TGF-β1) - 诱导MCS中的SetD7和突触性基因的表达和组蛋白修饰。此外,小鼠中的12/15-LO敲除DN和废除肾SET7和荧光基因的废除的关键特征。另外,体内12/15-Lo siRNA在糖尿病小鼠中的肾SET7和PROFIBROTIC基因中堵塞增加。创新和结论:这些新结果首次证明了12/15-LO-衍生的氧化脂质调节与MCS中的研究相关的组蛋白修饰,12/15-LO可以介导TGF-β1和糖尿病的类似作用。靶向12/15-LO可能是抑制DN中涉及的关键表观遗传机制的有用策略。 Antioxid。氧化还原信号。 24,361-375。

著录项

  • 来源
    《Antioxidants and redox signalling》 |2016年第7期|共15页
  • 作者单位

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    Jilin Univ Hosp 1 Dept Nephrol Changchun 130023 Peoples R China;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

    City Hope Natl Med Ctr Beckman Res Dept Diabet Complicat &

    Metab 1500 E Duarte Rd Duarte CA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 基础医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号